Published in Am J Surg Pathol on November 01, 1993
Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case. Med Mol Morphol (2009) 1.49
Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch (2004) 0.90
The gastric cardia in gastro-oesophageal disease. J Clin Pathol (2000) 0.86
Pancreatic acinar cells--a normal finding at the gastroesophageal junction? Data from a prospective Central European multicenter study. Virchows Arch (2013) 0.82
Heterotopic Pancreatic Tissue of the Stomach: Report of Three Cases and Consideration of Its Histogenesis. Case Rep Gastroenterol (2010) 0.79
Histopathological study using computer database of 10 000 consecutive gastric specimens: (1) benign conditions. Gastroenterol Rep (Oxf) (2015) 0.77
Cardiac mucosa at the gastroesophageal junction: An Eastern perspective. World J Gastroenterol (2015) 0.76
Pancreatic acinar metaplasia in the distal oesophagus and the gastric cardia: prevalence, predictors and relation to GORD. J Gastroenterol (2009) 0.75
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet (1997) 6.99
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol (2005) 5.27
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels. Ann Oncol (2002) 4.32
Twist is a potential oncogene that inhibits apoptosis. Genes Dev (1999) 3.14
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer (1996) 3.07
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst (1999) 2.90
Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut (2009) 2.75
Primary giant cell tumor of soft tissues: a study of 22 cases. Am J Surg Pathol (2000) 2.67
bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol (1997) 2.66
The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res (1996) 2.57
Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung. Am J Surg Pathol (2001) 2.42
Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol (1998) 2.40
p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol (2001) 2.19
Patterns of integrin common chain beta 1 and collagen IV immunoreactivity in hepatocellular carcinoma. Correlations with tumour growth rate, grade and size. J Pathol (1993) 2.12
Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol (2002) 2.03
Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Ann Oncol (2010) 2.02
Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. Lancet (1981) 2.02
1st International consensus guidelines for advanced breast cancer (ABC 1). Breast (2012) 1.96
[Who needs a gastroenterology pathologist?]. Pathologica (1997) 1.93
Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology (1996) 1.83
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement. Ann Oncol (2012) 1.69
Outcome of special types of luminal breast cancer. Ann Oncol (2011) 1.67
Cancer-testis antigen expression in triple-negative breast cancer. Ann Oncol (2010) 1.65
Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int (2007) 1.64
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. Ann Oncol (2005) 1.60
Radioguided sentinel lymph node biopsy in breast cancer surgery. J Nucl Med (2001) 1.57
Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. Br J Cancer (2003) 1.55
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial. Ann Oncol (2007) 1.54
Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med (1998) 1.53
Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol (1996) 1.52
The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer (1994) 1.51
Well-differentiated liposarcoma (atypical lipomatous tumors). Semin Diagn Pathol (2001) 1.51
Gastritis cystica profunda. Histopathology (1981) 1.50
Should liver metastases of breast cancer be biopsied to improve treatment choice? Ann Oncol (2011) 1.50
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol (2010) 1.47
Quality indicators in breast cancer care. Eur J Cancer (2010) 1.46
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study. Ann Oncol (2014) 1.45
The problem of the accuracy of intraoperative examination of axillary sentinel nodes in breast cancer. Ann Surg Oncol (2001) 1.45
Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer (1991) 1.42
Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO). Breast Cancer Res Treat (2009) 1.41
Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.39
Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res (1995) 1.39
Immunoreactivity for latent membrane protein 1 of Epstein-Barr virus in nevi and melanomas is not related to the viral infection. Virchows Arch (2000) 1.39
Fibroepithelial tumor of the breast with digital fibroma-like inclusions in the stromal component. Case report with immunocytochemical and ultrastructural analysis. Am J Surg Pathol (1994) 1.38
Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst (1994) 1.35
p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol (1995) 1.32
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol (2006) 1.29
Desmoplastic small round cell tumors of the paratesticular region. A report of six cases. Am J Surg Pathol (1997) 1.29
Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene (2007) 1.28
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol (2008) 1.23
Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg (1999) 1.22
Pulmonary epithelial-myoepithelial tumor of unproven malignant potential: report of a case and review of the literature. Mod Pathol (2001) 1.22
bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum Pathol (1995) 1.21
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse. Ann Oncol (2012) 1.19
Metastatic malignant melanoma showing a rhabdoid phenotype: further evidence of a non-specific histological pattern. Histopathology (1992) 1.18
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy. Ann Oncol (2007) 1.17
Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasms. J Pathol (1992) 1.16
Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group. Ann Oncol (2013) 1.16
Nodular hyperplasia of Brunner's glands. Gastrointest Endosc (1985) 1.16
Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor. Oncogene (2009) 1.16
Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer (2005) 1.14
p21/WAF1/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J Pathol (1996) 1.13
A simplified procedure for the preparation of antibodies to serum fibronectin. J Immunol Methods (1980) 1.13
Cyclin D3 expression in normal, reactive and neoplastic tissues. J Pathol (1998) 1.13
Resection of pulmonary blebs and pleurodesis for spontaneous pneumothorax. Chest (1993) 1.12
Sunitinib malate in solitary fibrous tumor (SFT). Ann Oncol (2012) 1.12
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes. Breast Cancer Res Treat (2011) 1.12
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int J Cancer (1996) 1.11
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions. Ann Oncol (2012) 1.11
Identification of a glioblastoma-associated tenascin-C isoform by a high affinity recombinant antibody. Am J Pathol (1999) 1.10
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies. Ann Oncol (2004) 1.10
p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations. Cancer (1997) 1.10
Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumour: report of three cases with molecular analysis and review of the literature. Endocr Relat Cancer (2005) 1.10
Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Am J Surg Pathol (1999) 1.10
Gastritis cystica polyposa: a possible precancerous lesion. Tumori (1985) 1.09
Discrete regions of HIV-1 gp41 defined by syncytia-inhibiting affinity-purified human antibodies. AIDS (1993) 1.09
Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects. Q J Nucl Med (2002) 1.08
Ultraviolet-induced p53 mutations in atypical fibroxanthoma. Am J Pathol (1994) 1.08
Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer (2001) 1.07
Cell junctions between spermatozoa flagella within the spermatozeugmata of Tubifex tubifex (Annelida: Oligochaeta). J Ultrastruct Res (1980) 1.07
Morphological changes of the gastroduodenal mucosa in regular dialysis uraemic patients. Histopathology (1982) 1.06
The clinical significance of p53 aberrations in human tumours. Virchows Arch (1995) 1.06
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol (2007) 1.06
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol (2006) 1.06
Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay. J Immunol (1998) 1.06
Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives. J Allergy Clin Immunol (1983) 1.06
Autophagy in term normal human placentas. Placenta (2011) 1.05
Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Br J Cancer (2007) 1.04
"Transitional" and hyperplastic-metaplastic mucosa occurring in solitary ulcer of the rectum. Histopathology (1981) 1.04
Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. J Pathol (2006) 1.04
Pathological and molecular diagnosis of triple-negative breast cancer: a clinical perspective. Ann Oncol (2012) 1.04
A study of immunoglobulin classes present on the membrane and in the cytoplasm of human tonsil plasma cells. Eur J Immunol (1976) 1.04
Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia. Semin Diagn Pathol (2001) 1.03